391 related articles for article (PubMed ID: 15377381)
1. Normal histone modifications on the inactive X chromosome in ICF and Rett syndrome cells: implications for methyl-CpG binding proteins.
Gartler SM; Varadarajan KR; Luo P; Canfield TK; Traynor J; Francke U; Hansen RS
BMC Biol; 2004 Sep; 2():21. PubMed ID: 15377381
[TBL] [Abstract][Full Text] [Related]
2. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
Martínez de Paz A; Ausió J
Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538
[TBL] [Abstract][Full Text] [Related]
3. X inactivation-specific methylation of LINE-1 elements by DNMT3B: implications for the Lyon repeat hypothesis.
Hansen RS
Hum Mol Genet; 2003 Oct; 12(19):2559-67. PubMed ID: 12925568
[TBL] [Abstract][Full Text] [Related]
4. ICF syndrome cells as a model system for studying X chromosome inactivation.
Gartler SM; Hansen RS
Cytogenet Genome Res; 2002; 99(1-4):25-9. PubMed ID: 12900541
[TBL] [Abstract][Full Text] [Related]
5. Lessons from two human chromatin diseases, ICF syndrome and Rett syndrome.
Matarazzo MR; De Bonis ML; Vacca M; Della Ragione F; D'Esposito M
Int J Biochem Cell Biol; 2009 Jan; 41(1):117-26. PubMed ID: 18786650
[TBL] [Abstract][Full Text] [Related]
6. MeCP2 and other methyl-CpG binding proteins.
Jørgensen HF; Bird A
Ment Retard Dev Disabil Res Rev; 2002; 8(2):87-93. PubMed ID: 12112733
[TBL] [Abstract][Full Text] [Related]
7. Influence of MECP2 gene mutation and X-chromosome inactivation on the Rett syndrome phenotype.
Chae JH; Hwang H; Hwang YS; Cheong HJ; Kim KJ
J Child Neurol; 2004 Jul; 19(7):503-8. PubMed ID: 15526954
[TBL] [Abstract][Full Text] [Related]
8. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
9. Genome-Wide DNA Methylation Analysis Identifies Novel Hypomethylated Non-Pericentromeric Genes with Potential Clinical Implications in ICF Syndrome.
Simo-Riudalbas L; Diaz-Lagares A; Gatto S; Gagliardi M; Crujeiras AB; Matarazzo MR; Esteller M; Sandoval J
PLoS One; 2015; 10(7):e0132517. PubMed ID: 26161907
[TBL] [Abstract][Full Text] [Related]
10. Escape from gene silencing in ICF syndrome: evidence for advanced replication time as a major determinant.
Hansen RS; Stöger R; Wijmenga C; Stanek AM; Canfield TK; Luo P; Matarazzo MR; D'Esposito M; Feil R; Gimelli G; Weemaes CM; Laird CD; Gartler SM
Hum Mol Genet; 2000 Nov; 9(18):2575-87. PubMed ID: 11063717
[TBL] [Abstract][Full Text] [Related]
11. Satellite 2 methylation patterns in normal and ICF syndrome cells and association of hypomethylation with advanced replication.
Hassan KM; Norwood T; Gimelli G; Gartler SM; Hansen RS
Hum Genet; 2001 Oct; 109(4):452-62. PubMed ID: 11702227
[TBL] [Abstract][Full Text] [Related]
12. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
Cheung AY; Horvath LM; Grafodatskaya D; Pasceri P; Weksberg R; Hotta A; Carrel L; Ellis J
Hum Mol Genet; 2011 Jun; 20(11):2103-15. PubMed ID: 21372149
[TBL] [Abstract][Full Text] [Related]
13. Temporal shift in methyl-CpG binding protein 2 expression in a mouse model of Rett syndrome.
Metcalf BM; Mullaney BC; Johnston MV; Blue ME
Neuroscience; 2006; 139(4):1449-60. PubMed ID: 16549272
[TBL] [Abstract][Full Text] [Related]
14. [X chromosome inactivation patterns in patients with Rett syndrome and their mothers and the parental origin of the priority inactive X chromosome].
Jiang SL; Bao XH; Song FY; Pan H; Li MR; Wu XR
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):648-52. PubMed ID: 17217653
[TBL] [Abstract][Full Text] [Related]
15. Histone H3 and H4 modification profiles in a Rett syndrome mouse model.
Urdinguio RG; Pino I; Ropero S; Fraga MF; Esteller M
Epigenetics; 2007; 2(1):11-4. PubMed ID: 17965622
[TBL] [Abstract][Full Text] [Related]
16. The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome.
Nan X; Bird A
Brain Dev; 2001 Dec; 23 Suppl 1():S32-7. PubMed ID: 11738839
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
Koizume S; Tachibana K; Sekiya T; Hirohashi S; Shiraishi M
Nucleic Acids Res; 2002 Nov; 30(21):4770-80. PubMed ID: 12409468
[TBL] [Abstract][Full Text] [Related]
18. X chromosome inactivation in Rett Syndrome and its correlations with MECP2 mutations and phenotype.
Xinhua Bao ; Shengling Jiang ; Fuying Song ; Hong Pan ; Meirong Li ; Wu XR
J Child Neurol; 2008 Jan; 23(1):22-5. PubMed ID: 18184939
[TBL] [Abstract][Full Text] [Related]
19. Abnormal methylation does not prevent X inactivation in ICF patients.
Bourc'his D; Miniou P; Jeanpierre M; Molina Gomes D; Dupont J; De Saint-Basile G; Maraschio P; Tiepolo L; Viegas-Péquignot E
Cytogenet Cell Genet; 1999; 84(3-4):245-52. PubMed ID: 10393442
[TBL] [Abstract][Full Text] [Related]
20. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA.
Ballestar E; Yusufzai TM; Wolffe AP
Biochemistry; 2000 Jun; 39(24):7100-6. PubMed ID: 10852707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
